Literature DB >> 29605767

The psoas muscle transversal diameter predicts mortality in patients with cirrhosis on a waiting list for liver transplantation: A retrospective cohort study.

Audrey Huguet1, Marianne Latournerie2, Pauline Houssel Debry1, Caroline Jezequel1, Ludivine Legros1, Michel Rayar3, Karim Boudjema3, Dominique Guyader4, Edouard Bardou Jacquet4, Ronan Thibault5.   

Abstract

OBJECTIVE: Malnutrition impairs prognosis in liver cirrhosis. Our aims were to determine (1) if transversal (TPTI) and axial (APTI) psoas thickness indices predict mortality in cirrhotic patients and (2) the feasibility and reproducibility of transversal (TDPM) and axial (ADPM) diameters of the psoas muscle measurements.
METHODS: This was a retrospective study. Inclusion criteria included cirrhosis diagnosis, on liver transplantation waiting list, and abdominal computed tomography (CT) scan within the 3 mo preceding list inscription. TDPM and ADPM were measured on a single umbilicus-targeted CT image by non-expert and expert operators. TPTI or APTI (mm/m) were calculated as TDPM or ADPM/height (m). Area under the receiver operating characteristic curve (AUC) and Cox proportional hazard models were assessed. TPTI and APTI interobserver agreement: κ correlation test.
RESULTS: A total of 173 patients were included. Low TPTI was associated with increased mortality: AUC = 0.66 (95% confidence interval, 0.51-0.80). TPTI was the only factor associated with mortality (hazard ratio = 0.87, 95% confidence interval 0.76-0.99, P = 0.034). There was an almost perfect interobserver agreement between the two operators: TDPM, κ = 0.97; ADPM, κ = 0.94; P <0.0001.
CONCLUSIONS: TPTI measured on umbilicus-targeted CT scan before inscription on the waiting list for liver transplantation predicts mortality of cirrhotic patients. TPTI measurement is easy and reliable, even by a non-trained operator, and this is highly feasible in daily clinical practice.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography scan; Liver failure; Liver graft; Malnutrition; Muscle mass; Sarcopenia

Mesh:

Year:  2018        PMID: 29605767     DOI: 10.1016/j.nut.2018.01.008

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  9 in total

1.  Muscle Mass Is Linked to Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease.

Authors:  Toshifumi Yodoshi; Sarah Orkin; Ana-Catalina Arce Clachar; Kristin Bramlage; Qin Sun; Lin Fei; Andrew F Beck; Stavra A Xanthakos; Andrew T Trout; Marialena Mouzaki
Journal:  J Pediatr       Date:  2020-08       Impact factor: 4.406

2.  A Pilot Study of Racial Differences in the Current Definition of Sarcopenia among Liver Transplant Candidates.

Authors:  Tomoki Sempokuya; Leigh Yokoyama-Arakaki; Linda L Wong; Sumodh Kalathil
Journal:  Hawaii J Health Soc Welf       Date:  2020-05-01

3.  Muscle mass ratio in male gastric cancer patients as an independent predictor of postoperative complications after minimally invasive distal gastrectomy.

Authors:  Gaku Inaguma; Susumu Shibasaki; Masaya Nakauchi; Akiko Serizawa; Kenichi Nakamura; Shingo Akimoto; Tanaka Tsuyoshi; Kazuki Inaba; Ichiro Uyama; Koichi Suda
Journal:  Surg Endosc       Date:  2022-09-09       Impact factor: 3.453

4.  Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.

Authors:  Michael Praktiknjo; Caroline Clees; Alessandra Pigliacelli; Stefan Fischer; Christian Jansen; Jennifer Lehmann; Alessandra Pohlmann; Barbara Lattanzi; Viktoria Katharina Krabbe; Christian P Strassburg; Vicente Arroyo; Manuela Merli; Carsten Meyer; Jonel Trebicka
Journal:  Clin Transl Gastroenterol       Date:  2019-04       Impact factor: 4.488

5.  The value of different CT-based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis.

Authors:  Rafael Paternostro; Katharina Lampichler; Constanze Bardach; Ulrika Asenbaum; Clara Landler; David Bauer; Mattias Mandorfer; Remy Schwarzer; Michael Trauner; Thomas Reiberger; Arnulf Ferlitsch
Journal:  Liver Int       Date:  2019-09-11       Impact factor: 5.828

6.  Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension.

Authors:  Rafael Paternostro; Constanze Bardach; Benedikt S Hofer; Bernhard Scheiner; Philipp Schwabl; Ulrika Asenbaum; Ahmed Ba-Ssalamah; Martina Scharitzer; Theresa Bucscis; Benedikt Simbrunner; David Bauer; Michael Trauner; Mattias Mandorfer; Thomas Reiberger; Katharina Lampichler
Journal:  Liver Int       Date:  2020-12-22       Impact factor: 5.828

7.  Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure.

Authors:  Tsung-Yi Cheng; Pei-Chang Lee; Yi-Tzen Chen; Yee Chao; Ming-Chih Hou; Yi-Hsiang Huang
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

8.  Value of the controlling nutritional status score and psoas muscle thickness per height in predicting prognosis in liver transplantation.

Authors:  Xing Dai; Ben Gao; Xin-Xin Zhang; Jiang Li; Wen-Tao Jiang
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

9.  Usefulness of computed tomography-measured psoas muscle thickness per height for predicting mortality in patients undergoing hemodialysis.

Authors:  Takahiro Yajima; Maiko Arao; Kumiko Yajima; Hiroshi Takahashi
Journal:  Sci Rep       Date:  2021-09-24       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.